A. Skyschally, M. Haude, H. Dorge, M. Thielmann, A. Duschin, A. van de Sand, I. Konietzka, A. Buchert, S. Aker, et al., “Glucocorticoid Treatment Prevents Pro- gressive Myocardial Dysfunction Resulting from Experi- mental Coronary Microembolization,” Circulation, Vol. 109, No. 19, 2004, pp. 2337-2342. doi:10.1161/01.CIR.0000127961.66744.F4

has been cited by the following article:

• TITLE: An Overview of the Consequences of Distal Coronary Microembolization on Left Ventricular Function, Perfusion and Viability

  AUTHORS: Maythem Saeed

  KEYWORDS: Distal Coronary Microemblolization, Microinfarct, Left Ventricular Function, Cardiac Imaging

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.2 No.1, February 24, 2011

  ABSTRACT: Annually, an estimated 1,285,000 in-patient angioplasty procedures, 1,471,000 inpatient diagnostic cardiac catheteri-zations and 68,000 inpatient defibrillator implantations are performed. The direct and indirect cost of cardiovascular diseases for 2007 is approximately $431.8 billion. The occurrence of plaque rupture with subsequent microemboli of atherosclerotic and thrombolytic debris into small coronary vessels has been confirmed. Microinfarction results from microemboli that are shed following coronary interventions. The aims of this review are to: 1) detect heterogeneous microinfarction using viability imaging, 2) characterize the consequences of distal coronary microembolization on left ventricle function and perfusion and 3) illustrate the progress of non-invasive imaging modalities in assessing distal coronary microembolization.